1,3-dipropyl-8-cyclopentylxanthine has been researched along with okadaic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, S; Jones, KH; Kang-Park, MH; Moore, SD; Sarda, MA; Shenolikar, S; Wilson, WA | 1 |
| Gomi, S; Hirose, M; Hongo, M; Kashihara, T; Nakada, T; Shimojo, H; Yamada, M | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and okadaic acid
| Article | Year |
|---|---|
Protein phosphatases mediate depotentiation induced by high-intensity theta-burst stimulation.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Calcineurin; Calcineurin Inhibitors; Cyclic AMP-Dependent Protein Kinases; Electrophysiology; Enzyme Inhibitors; Hippocampus; Male; Marine Toxins; Membrane Potentials; Okadaic Acid; Organ Culture Techniques; Oxazoles; Phosphodiesterase Inhibitors; Phosphoprotein Phosphatases; Rats; Rats, Sprague-Dawley; Theta Rhythm; Xanthines | 2003 |
β(2)-Adrenergic and M(2)-muscarinic receptors decrease basal t-tubular L-type Ca2+ channel activity and suppress ventricular contractility in heart failure.
Topics: Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Calcium Channels, L-Type; Enzyme Inhibitors; Heart Failure; Male; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Myocardial Contraction; Okadaic Acid; Phosphoprotein Phosphatases; Propanolamines; Receptor, Muscarinic M2; Receptors, Adrenergic, beta-2; Ventricular Function, Left; Xanthines | 2014 |